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Abstract
Background: Candida species have become the fourth most-frequent cause of nosocomial
bloodstream infections in immunocompromised patients. Therefore, rapid identification of
pathogenic fungi to species level has been considered critical for treatment. Conventional
diagnostic procedures such as blood culture or biochemical tests are lacking both sensitivity and
species specificity, so development of rapid diagnostic is essential.
Results: An immunomagnetic method involving anti-Candida monoclonal antibodies was
developed to capture and concentrate in human blood four different species of Candida cells
responsible for invasive yeast infections. In comparison with an automated blood culture,
processing time of immunomagnetic separation is shorter, saving at least 24 hours to obtain
colonies before identification.
Conclusion: Thus, this easy to use method provides a promising basis for concentrating all
Candida species in blood to improve sensitivity before identification.
Background
Candida spp. is now the fourth most frequent cause of
nosocomial blood-stream infections in critically ill
patients and Candida. albicans is the most prevalent spe-
cies [1,2]. Prevalence of other species such as Candida trop-
icalis, Candida glabrata, Candida parapsilosis and Candida
krusei varies according to clinical conditions [3]. Rapid
isolation and identification of pathogenic yeasts to species
level is critical for treatment. Conventional diagnostic
procedures, such as blood culture and biochemical tests
lack the degree of sensitivity and specificity that would
ensure reliable and early diagnosis of invasive Candida
infections [4,5]. As a consequence, methods based on the
amplification and detection of yeast DNA have been
developed. Conventional PCR techniques and now real-
time PCR assays are performed for specific and rapid
detection and identification of fungi from clinical isolates
[6]. However, as yeast load is often lower than 10 CFU per
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infection [7], sensitivity is the major drawback with these
techniques. Sensitivity can be improved by coupling PCR
method with other methods, such as hybridization assay
[8], by using nested [5,9] or by optimising DNA extraction
methods [10,11]. However availability of pure DNA with-
out PCR inhibitors is essential. Another approach is to
concentrate yeast cells before culture or DNA extraction
using techniques such as the immunomagnetic separation
method (IMS) where magnetic beads coated with mono-
clonal antibodies are used to capture yeast cells present in
clinical specimens.
The purpose of this study was to evaluate the usefulness of
IMS in improving culture yields. The effectiveness of the
IMS was determined and the time to obtain colonies of
Candida species was compared to that of the Bactec Myco-
sis-IC/F automated blood culture system. Human blood
artificially contaminated with C. albicans, C. tropicalis
which are the most frequently strains isolated in candi-
demia was used. C. glabrata and C. krusei were also
included in the study because of their reduced susceptibil-
ity i.e. higher resistance to fluconazole.
Results and discussion
Analytical sensitivity of IMS
Percentages of viable yeast cells captured by beads were
calculated in relation to counts of viable cells initially
present in inoculated blood and expressed for 1 ml of
blood (Table 1). It was observed that yeast cells of all
strains studied could be recovered by IMS, but with varia-
ble recovery rates. 27.5% and 29.1% for the two strains of
C. albicans (respectively 5575 and ATCC 66396), 38% for
the two C. glabrata isolates (5511 and 5484) and about
15% for the two C. tropicalis isolates (5437 and 5395). It
was moreover noted that immunoseparation recovery
rates were more variable for C. krusei with 10.8% for iso-
late 5374 and 43.2% for isolate 5481. A possible explana-
tion for the lower recovery rate of isolate 5374 is that the
antigen recognised by Mab 6B3 might have been
expressed at lower level in this strain. Nevertheless, IMS
appears as an easy method allowing yeast cells immuno-
capture in less than one hour and colonies of the four
Candida species tested after 24 h of culture on SDA-C. If
IMS is coupled with a culture on chromogenic medium, it
can allow the differentiation and presumptive identifica-
tion of the pathogen within 24 hours. C. parapsilosis was
not tested because it is not well recognised by the MAb
5B2. The introduction of beads coated with other specific
MAbs (i.e. against C. parapsilosis) in the mix is expected to
result in a technique for concentrating all major patho-
genic Candida species in blood
IMS method in comparison with conventional procedures
The IMS method has several advantages over conven-
tional methods: it is easy to use, no special equipment is
required, processing time of IMS is shorter.
In our study, with the automated blood culture method,
microbial growth could be detected for all strains of Can-
dida after an incubation of about 24 h (Table 1). However,
the viable colonies needed to perform identification were
only obtained after subsequent sub-culturing and this
required a further 24-h incubation. Despite efforts made
by many investigators, early and rapid diagnosis of sys-
temic yeast infections remains limited. Culture detection
of Candida species is often delayed or remains negative
because of slow or absent growth of yeast isolates from
clinical specimens. Blood cultures are positive for fewer
than 50% of patients with invasive candidiasis [2,5].
Then, time to obtain colonies is shorter with IMS, saving
at least 24 h in comparison with blood culture. Of course,
further optimization should seek for best IMS recovery
rates to increase its lower limit of detection.
Table 1: Analytical sensitivity of Candida cells capture with IMS method
Strains Time (hours) of positive 
blood culture
(mean ± SD)a






Candida albicans 5575 25.45 ± 0.59 32 8.8 ± 0.6 27.5 ± 1.9
Candida albicans ATCC 66396 25.95 ± 1.46 6 1.75 ± 0.3 29.1 ± 3.8
Candida krusei 5374 22.26 ± 0.48 30 3.25 ± 0.5 10.8 ± 1.7
Candida krusei 5481 16.20 ± 0.28 40 17.3 ± 2.5 43.2 ± 6.2
Candida glabrata 5511 25.05 ± 0.5 20 7.6 ± 1.3 38 ± 6.4
Candida glabrata 5484 25.38 ± 0.58 10 3.8 ± 0.6 38 ± 6.3
Candida tropicalis 5437 19.02 ± 0.88 30 4.8 ± 2.2 16 ± 3.8
Candida tropicalis 5395 17.51 ± 0.50 30 4.3 ± 2.2 14.3 ± 7.3
acalculation of mean and SD is derived from three different experiments
bpercentage of immunocaptured cells: number of CFU per 1 ml of blood after IMS procedure/number of CFU per 1 ml of blood in initial 
contaminated blood
CFU: Colony Forming Unit, IMS : ImmunoMagnetic Separation, SD : Standard DeviationPage 2 of 4
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increase the efficiency of culture or the yield of nucleic
acid before a DNA extraction. PCR assays that amplify a
highly conserved sequence of the multicopy rRNA gene
were developed using DNA extracts from blood speci-
mens. 1 to 5 CFU/ml has been reported as a lower limit
for DNA detection by PCR. It was shown that IMS com-
bined with real-time PCR to detect Plasmodium falciparum
in blood samples [12], or bacteria such as Escherichia coli
0157:H7 and Listeria monocytogenes in food [13-15], or
some viruses (Hepatitis A virus, Norovirus) from environ-
mental samples or food [16,17] is particularly attractive
because of the potential for concentrating micro-organ-
isms. Therefore IMS, in conjunction with PCR, considered
as one of the most sensitive methods to detect low levels
of DNA from pathogens in clinical samples, could be a
helpful tool in the diagnosis of candidemia.
Conclusion
In our study, IMS has been used to capture yeast cells from
artificially contaminated human blood using magnetic
beads coated with monoclonal antibodies (MAb 5B2 and
MAb 6B3) specific to surface antigens of Candida. When
numbers of CFU ranged from 6 to 40 CFU per ml of
blood, IMS allowed immunocapture for the four Candida
species studied. We are fully aware that it is a study using
artificially contaminated blood and another study is now
in progress to evaluate what really happens in natural can-
didemia.
IMS should be useful in order to facilitate the isolation of
yeasts from blood saving at least 24 h to obtain colonies
before classic identification.
Methods
Strains and culture conditions
One ATCC reference strain and 7 Candida spp. isolated
from clinical samples taken during invasive candidiasis
were used: C. albicans ATCC 66396, 1 clinical strains of C.
albicans (5575), two clinical isolates of each of C. glabrata
(5511, 5484),C. krusei (5374, 5481), and C. tropicalis
(5437, 5395).
Blastoconidia were grown for 24 h at 37°C on Sabouraud-
dextrose-agar (SDA) containing chloramphenicol 1 mg/
ml (SDA-C). Then 1 colony was suspended in 10 ml of
sterile distilled water and the suspension was plated on
SDA-C and incubated for 24 h at 37°C. Blastoconidia
were removed with a rubber policeman and suspended
into 4 ml of sterile distilled water. A dilution of 0.5 × 10-6
of this suspension was prepared in distilled water to
obtain a working yeast suspension and then the number
of CFU was calculated by plating 100 μl of this fungal
dilution on SDA-C.
Immunomagnetic separation method versus blood culture
Immunomagnetic beads (Estapor® Merck, France) coated
with MAb 5B2 or MAb 6B3 (2 mg/ml) were obtained from
SR2B (Avrillé, France) [18,19]. MAb 5B2 recognises the
predominantly polysaccharidic antigen present on the cell
surface of several species of Candida (C. albicans, C. gla-
brata, C. tropicalis) [20]. It is thought that the reactive
structures recognised by MAb 5B2 consist of man-
nopyranosyl units bound through β(1–2) linkages. MAb
6B3 reacts specifically with a cell wall surface antigen that
was found to be expressed by all C. krusei strains or iso-
lates [19].
Following the recommendations of the manufacturer of
the automated culture system that 3 to 10 ml of blood
should be inoculated into Bactec Mycosis-IC/F culture
vials (Becton Dickinson, Pont de Claix, France), both
methods, IMS and blood culture, were carried out using
samples of 4 ml of human blood for consistency.
200 μl samples of the working yeast suspension were
added to 10 ml of human blood. For the blood used in
this study, our institution has an agreement with the
«Etablissement Français du Sang» for research experi-
ments. After shaking, 4 ml of this contaminated blood
were inoculated into Bactec fungal medium and microbial
growth was detected by fluorescence (Bactec BD9240,
Beckton Dickinson). When positive, samples were sub-
cultured onto SDA-C medium to obtain colonies.
Separately, for the IMS procedure, 4 ml of the same yeast
contaminated blood were lysed using 4 ml of lysis buffer
consisting of 5 mM Tris (pH 7.5), 5 mM EDTA (pH 8) and
2% Triton X® 100 by shaking for 5 min at 22°C, in order
to lyse erythrocytes and leukocytes and particularly poly-
nuclear neutrophils which could contain intracytoplasmic
yeasts. A mix of 50 μl magnetic beads coated with MAb
5B2 and 50 μl of magnetic beads coated with MAb 6B3,
were then added. After incubation for 30 min at 22°C in
an incubator (Mini Artic, Jouan, France) with gentle agita-
tion on a sample mixer (Dynal, France), the tubes were
put in a magnetic device (Dynal) in order to separate the
beads from the supernatant which was discarded. The
beads were then re-suspended in 100 μl of 5 mM Tris (pH
7.5), 5 mM EDTA (pH 8) before being plated onto SDA-
C. After incubation for 24 h at 37°C, number of CFU, cor-
responding to viable cells which was obtained from 4 ml
of blood were expressed per 1 ml of blood. This number
of CFU per 1 ml after IMS was compared with the number
of CFU determined from 1 ml of blood in the initial con-
taminated blood. The results were expressed in percent-
ages of immunocaptured cells. All experiments were
performed in triplicate.Page 3 of 4
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